This inventor holds 4 USPTO granted patents. Top assignees: Imperial Chemical Industries Limited, Ici Pharma, Zeneca Limited. Active years: 1982-1995.
Company Filing History:


Years Active: 1982-1995
Title: The Innovative Journey of Jonathan Hutton
Introduction
Jonathan Hutton is a notable inventor based in Adlington, GB. He has made significant contributions to the field of chemistry, particularly in the development of quinolinium salts and triazolotriazines. With a total of 4 patents to his name, Hutton's work has implications in various pharmaceutical applications.
Latest Patents
Hutton's latest patents include the invention of crystalline 1-alkyl-2-quinolinium salts. This invention concerns quinolinium salt intermediates and processes for their manufacture, which are essential in producing aryloxymethyl-substituted 1-alkyl-2-quinolone derivatives that act as 5-lipoxygenase inhibitors. Another significant patent involves a chemical process for preparing a 5,7-diaryloxy-2-(2-heteroaryl)-triazolo[1,5-a][1,3,5]triazine. This process includes reacting a specific hydrazine with a polyphosphoric acid silyl ester, leading to the development of triazolotriazines with activity as adenosine antagonists.
Career Highlights
Throughout his career, Jonathan Hutton has worked with prominent companies, including Imperial Chemical Industries Limited and ICI Pharma. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking innovations in the chemical industry.
Collaborations
Hutton has collaborated with various professionals in his field, including his coworker David Waterson. These partnerships have fostered an environment of creativity and innovation, leading to the successful development of new chemical processes and compounds.
Conclusion
Jonathan Hutton's contributions to the field of chemistry through his patents and collaborations highlight his innovative spirit and dedication to advancing pharmaceutical science. His work continues to influence the industry and pave the way for future discoveries.